A clinical comparison of two different prednisolone acetate formulations in patients undergoing cataract surgery

Current Medical Research and Opinion

Volumn 21, Issue 8, 2005, Pages 1291-1295

  Gayton, Johnny L ^a,b  

^a EyeSight Associates   (United States)

^b NONE   (United States)

Author keywords

Cataract inflammation; Cystoid macular edema; Prednisolone acetate

Indexed keywords

DICLOFENAC; ECONOPRED PLUS; GUAR GUM; HYDROXYPROPYL GUAR; PREDNISOLONE ACETATE; SYSTANE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTERIOF EYE CHAMBER CELL; ANTERIOR EYE CHAMBER DISEASE; ANTERIOR EYE CHAMBER FLARE; ARTICLE; CATARACT; CATARACT EXTRACTION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DRUG EFFICACY; DRUG FORMULATION; EYE INFLAMMATION; FEMALE; HUMAN; KERATITIS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STEROID THERAPY;

AGED; CATARACT EXTRACTION; FEMALE; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; LENS IMPLANTATION, INTRAOCULAR; MACULAR EDEMA, CYSTOID; MALE; POSTOPERATIVE CARE; PREDNISOLONE; TREATMENT OUTCOME;

EID: 23744445176     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079905X56538     Document Type: Article

References (15)

1. Bilge AH, Aykan U, Akin T, Unsal U. Review of sterile, postoperative, anterior segment inflammation following cataract extraction and intraocular lens implantation. Eur J Ophthalmol. 2005;15:224-7
2. Goguen ER, Roberts CW. Topical NSAIDs to control pain in clear corneal cataract exraction. Insight 2004;29:10-1
3. Notivol R, Bertin D, Amin D, et al. Comparison of topical tobramycin-dexamethasone with dexamethasone-neomycin-polymyxin and neomycin-polymyxin-gramicidin for control of inflammation after cataract surgery: results of a multicenter, prospective, three-arm, randomized, double-masked controlled, parallel-group study. Clin Ther 2004;26:1274-85
4. Flach AJ, Dolan BJ, Donahue ME, et al. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery. Ophthal 1998;105:1775-9
5. McColgin AZ, Heier JS. Control of intraocular inflammation associated with cataract surgery. Curr Opin Ophthal 2000;11:3-6
6. McGhee CN, Dean S, Danesh-Meyer H. Locally administered ocular corticosteroids: benefits and risks. Drug Saf 2002;25:33-55
7. Holmberg BJ, Maggs DJ. The use of corticosteroids to treat ocular inflammation. Vet Clin North Am Small Anim Pract 2004;34:693-705
8. Avunduk AM, Avunduk MC, Varnell ED, Kaufman HE. The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study. Am J Ophthalmol 2003;136:593-602
9. Schalnus R. Topical nonsteroidal anti-inflammatory therapy in ophthalmology. Ophthalmologica 2003;217:89-98
10. Gaynes BI, Fiscella R. Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review. Drug Saf 2002;25:233-50
11. Hayasaka Y, Hayasaka S, Zhang XY, Nagaki Y. Effects of topical corticosteroids and nonsteroidal anti-inflammatory drugs on prostaglandin E2-induced aqueous flare elevation in pigmented rabbits. Ophthalmic Res 2003;35:341-4
12. Diestelhorst M, Kwon KA, Suverkrup R. Dose uniformity of ophthalmic suspensions. J Cataract Refract Surg 1998;24:672-7
13. Bisrat M, Glazer M, Camber O, Edman P. Effect of particle size on ocular permeability of prednisolone acetate in rabbits. Acta Pharm Nord 1992;4:5-8
14. Nelson PL, Roberts C. Comparative analysis of prednisolone acetate suspensions. Invest Ophthalmol Vis Sci 2005;46(Suppl):1750
15. FDA Electronic Orange Book. Food and Drug Administration website. Available at: http://www.fda.gov/cder/ob/default.htm [Accessed June 21, 2005]